How to reconstitute NAD+ and precursors: mixing and storage
NAD+ helps cells use energy; wellness injection benefits remain unproven.
Also called: NAD+, NAD, nicotinamide adenine dinucleotide, coenzyme I, DPN, NR, nicotinamide riboside, NMN, β-NMN, nicotinamide mononucleotide.
NAD+ and precursors · NAD+ coenzyme and vitamin B3-derived precursors.
Comes as: Compounded NAD+ injection solution, Lyophilized NAD+ vials reported online, Oral NR capsules and NMN powder/tablets, Sublingual NMN tablets, NAD+ iontophoresis patches in a study.
Mixed with: Forum reports use bacteriostatic water. Clinical studies used controlled preparations; the correct diluent is product-specific..
Common vial sizes: 100, 500, 1000 mg. Common water amounts: 1, 3, 5 mL.
- These vial sizes and water volumes are community reports, not an approved label.
- A forum example used 100 mg with 1 mL, 500 mg with 3 mL, or 1000 mg with 5 mL.
- Syringe units are volume, not milligrams. Never transfer a unit count between different concentrations.
- No validated universal expiry after mixing was found; do not infer 28-day chemical stability from the diluent.
Before mixing: No universal validated storage rule was found. Use the exact product instructions; oral and injectable products differ.
After mixing: No universal post-mixing stability or beyond-use time was verified. Refrigeration does not make a contaminated vial safe.
Related to NAD+ and precursors
- MOTS-c: A peptide the body makes; injection benefits and safety remain unproven.
- SS-31 (elamipretide): A peptide approved for Barth syndrome muscle strength; benefit needs confirmation and broader energy benefits remain unproven.
Sources
- GenoGenix LLC - 718739 - 01/20/2026, FDA · FDA · 2026
- Safety of beta-nicotinamide mononucleotide (β-NMN) pursuant the regulation (EU) 2015/2283 and the bioavailability of nicotinamide from this source in the context of Directive 2002/46/EC., Turck et al. · EFSA journal. European Food Safety Authority · 2026
- The 2026 Prohibited List, World Anti-Doping Agency · WADA · 2026
- 503A Categories Update for September 2024, FDA · FDA · 2025
- DailyMed - NALTREXONE HYDROCHLORIDE tablet, film coated, DailyMed · 2023
- Safety of nicotinamide riboside chloride as a novel food pursuant to Regulation (EU) 2015/2283 and bioavailability of nicotinamide from this source, in the context of Directive 2002/46/EC., Turck et al. · EFSA journal. European Food Safety Authority · 2019
- FDA reminds compounders to use ingredients suitable for sterile compounding, FDA
- FDA to Compounders: Know Your Bulks and Excipients Suppliers, FDA
- Item: /regulated-product-applications/id/application/RP-2116, Food Standards Agency
- Nicotinamide riboside chloride, Food Standards Agency
- NMN 500 (531006), Therapeutic Goods Administration
- Product information, Health Canada
- Re: Docket Number FDA-2023-P-0872, FDA
- Submitted 75-Day Premarket Notifications for New Dietary Ingredients, FDA
- TUE Physician Guidelines: Intravenous infusions and/or injections, World Anti-Doping Agency
Sources checked: 2026-10-18.
Information only, not medical advice. Peptifacts does not sell anything and does not link to sellers.